Eargo announced that it received a letter from The Nasdaq Stock Market dated February 1 informing Eargo that the Company’s minimum bid price deficiency has been cured. The letter from Nasdaq follows the Company’s 1-for-20 reverse stock split approved by stockholders on October 12.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EAR: